Grown Rogue International Inc. (GRIN.CN)
CAD 0.94
(2.17%)
CAD 0.94
(2.17%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 8.05 Million USD | 144.27% |
| 2022 | 3.41 Million USD | 29.23% |
| 2021 | 2.55 Million USD | 479.27% |
| 2020 | -701.4 Thousand USD | 82.56% |
| 2019 | -3.85 Million USD | 7.46% |
| 2018 | -4.23 Million USD | -6882.23% |
| 2017 | -59.73 Thousand USD | 93.69% |
| 2016 | -947.17 Thousand USD | -100.67% |
| 2015 | 2.72 Million USD | 82.97% |
| 2014 | -2.77 Million USD | -396.34% |
| 2013 | -3.96 Million USD | 39.22% |
| 2012 | -918.47 Thousand USD | -26.6% |
| 2011 | -346.1 Thousand USD | -42.17% |
| 2010 | -556.38 Thousand USD | -454.28% |
| 2009 | -92.06 Thousand USD | -97.84% |
| 2008 | -47.03 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.74 Million USD | 0.0% |
| 2024 Q3 | 1.09 Million USD | -37.03% |
| 2023 Q3 | 1.92 Million USD | 10.36% |
| 2023 FY | - USD | 144.27% |
| 2023 Q2 | 1.74 Million USD | 22.53% |
| 2023 Q1 | 1.42 Million USD | 146.24% |
| 2023 Q4 | 2.95 Million USD | 53.09% |
| 2022 Q1 | 832.33 Thousand USD | -65.94% |
| 2022 Q3 | 724.49 Thousand USD | 0.18% |
| 2022 Q4 | 579.46 Thousand USD | -20.02% |
| 2022 Q2 | 723.17 Thousand USD | -13.12% |
| 2022 FY | - USD | 29.23% |
| 2021 Q3 | 962.61 Thousand USD | 503.37% |
| 2021 FY | - USD | 479.27% |
| 2021 Q4 | 2.44 Million USD | 153.88% |
| 2021 Q1 | -560.72 Thousand USD | -569.47% |
| 2021 Q2 | -238.64 Thousand USD | 57.44% |
| 2020 FY | - USD | 82.56% |
| 2020 Q4 | -83.75 Thousand USD | 59.95% |
| 2020 Q2 | -344.98 Thousand USD | -1346.51% |
| 2020 Q3 | -209.15 Thousand USD | 39.37% |
| 2020 Q1 | 27.67 Thousand USD | 102.48% |
| 2019 Q2 | -1.47 Million USD | -114.47% |
| 2019 Q4 | -1.11 Million USD | -96.32% |
| 2019 FY | - USD | 7.46% |
| 2019 Q1 | -689.38 Thousand USD | 45.67% |
| 2019 Q3 | -567.34 Thousand USD | 61.63% |
| 2018 Q3 | -127.37 Thousand CAD | -30.83% |
| 2018 FY | - USD | -6882.23% |
| 2018 Q4 | -1.26 Million USD | -896.13% |
| 2018 Q2 | -97.35 Thousand USD | -32.28% |
| 2018 Q1 | -73.59 Thousand USD | 23.89% |
| 2017 Q3 | -1.49 Million USD | -868.41% |
| 2017 Q2 | -154.59 Thousand USD | -21.23% |
| 2017 Q1 | -127.52 Thousand USD | 66.51% |
| 2017 FY | - USD | 93.69% |
| 2017 Q4 | -96.69 Thousand USD | 93.54% |
| 2016 Q3 | -187.67 Thousand USD | 71.23% |
| 2016 FY | - USD | -100.67% |
| 2016 Q2 | -652.34 Thousand USD | -80.8% |
| 2016 Q4 | -380.74 Thousand USD | -102.87% |
| 2016 Q1 | -360.81 Thousand CAD | -729.82% |
| 2015 Q1 | -203.48 Thousand USD | 0.96% |
| 2015 Q4 | -43.48 Thousand USD | -117.61% |
| 2015 Q3 | 246.94 Thousand USD | 176.05% |
| 2015 Q2 | -324.71 Thousand USD | -59.57% |
| 2015 FY | - USD | 82.97% |
| 2014 Q1 | -86.1 Thousand USD | -37.71% |
| 2014 FY | - USD | -396.34% |
| 2014 Q2 | -36.71 Thousand USD | 57.36% |
| 2014 Q3 | -176.34 Thousand USD | -380.26% |
| 2014 Q4 | -205.46 Thousand USD | -16.51% |
| 2013 Q1 | -161.54 Thousand USD | -15.44% |
| 2013 FY | - USD | 39.22% |
| 2013 Q4 | -62.52 Thousand USD | 60.94% |
| 2013 Q3 | -160.05 Thousand USD | -125.65% |
| 2013 Q2 | -70.93 Thousand USD | 56.09% |
| 2012 Q3 | 1.6 Million USD | 1050.97% |
| 2012 FY | - USD | -26.6% |
| 2012 Q2 | -168.34 Thousand USD | 88.62% |
| 2012 Q1 | -1.47 Million USD | -64.16% |
| 2012 Q4 | -139.94 Thousand USD | -108.74% |
| 2011 Q3 | -46.07 Thousand USD | 79.12% |
| 2011 Q4 | -901.48 Thousand USD | -1856.78% |
| 2011 Q1 | -45.02 Thousand USD | 16.96% |
| 2011 FY | - USD | -42.17% |
| 2011 Q2 | -220.67 Thousand USD | -390.08% |
| 2010 Q3 | -404.32 Thousand USD | -524.56% |
| 2010 Q2 | -64.73 Thousand USD | -148.62% |
| 2010 Q1 | -26.03 Thousand USD | 60.93% |
| 2010 FY | - USD | -454.28% |
| 2010 Q4 | -54.22 Thousand USD | 86.59% |
| 2009 Q4 | -66.65 Thousand USD | 41.84% |
| 2009 Q1 | -8119.45 USD | -45.32% |
| 2009 FY | - USD | -97.84% |
| 2009 Q3 | -114.6 Thousand USD | -128.25% |
| 2009 Q2 | -50.2 Thousand USD | -518.38% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | -5587.41 USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 232.682% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | 500.831% |
| Blueberries Medical Corp. | -1.22 Million CAD | 759.581% |
| The BC Bud Corporation | -1.19 Million CAD | 773.795% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 224.274% |
| CordovaCann Corp. | -1.6 Million CAD | 602.845% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | 407.179% |
| Captor Capital Corp. | 2.42 Million CAD | -232.843% |
| City View Green Holdings Inc. | -2.01 Million CAD | 500.042% |
| 1CM Inc. | 1.31 Million CAD | -513.515% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | 32603.864% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 464.911% |
| IM Cannabis Corp. | -2.79 Million CAD | 388.842% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 283.057% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | 2154.654% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 352.386% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | -605.911% |
| Ovation Science Inc. | -778.83 Thousand CAD | 1134.714% |
| Pharmadrug Inc. | -1.33 Million CAD | 703.641% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 233.068% |
| RAMM Pharma Corp. | -6.3 Million CAD | 227.873% |
| RIV Capital Inc. | -20.28 Million CAD | 139.736% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 244.034% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 110.386% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 373.109% |
| 1933 Industries Inc. | -10.03 Million CAD | 180.322% |
| Red Light Holland Corp. | -5.25 Million CAD | 253.328% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | 1149.317% |
| Xebra Brands Ltd. | -1.49 Million CAD | 639.044% |
| Adastra Holdings Ltd. | -1.41 Million CAD | 671.026% |